Evidence map›Paper›PMID 40796671›Full record

ArticleProstate cancer and prostatic diseases2025

Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Nicholas A Zorko *Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA. zorko004@umn.edu.ORCID http://orcid.org/0000-0001-7021-968X
Allison Makovec *Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.ORCID http://orcid.org/0009-0008-2487-9079
Andrew ElliottCaris Life Sciences, Phoenix, AZ, USA.
Samuel KellenMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
John R LozadaMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Ali T ArafaMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Martin FelicesMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Madison ShackelfordMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Pedro BarataUniversity Hospital Seidman Cancer Center, Cleveland, OH, USA.
Yousef ZakhariaHolden Comprehensive Cancer Center, Iowa City, IA, USA.ORCID http://orcid.org/0000-0001-9480-2626
Vivek NarayanAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-8205-738X
Mark N SteinHerbert Irving Comprehensive Cancer Center, Columbia University New York, New York, NY, USA.
Kevin K ZarrabiSidney Kimmel Cancer Center, Jefferson Medical College, Philadelphia, PA, USA.
Akash PatnaikUniversity of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
Mehmet A BilenWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Milan RadovichCaris Life Sciences, Phoenix, AZ, USA.
George SledgeCaris Life Sciences, Phoenix, AZ, USA.
Wafik S El-DeiryLegorreta Cancer Center, Brown University, Providence, RI, USA.
Elisabeth I HeathKarmanos Cancer Institute, Wayne State University, Detroit, MI, USA.ORCID http://orcid.org/0000-0003-1381-2713
Dave S B HoonSaint John's Cancer Institute, Saint John's Health Center PHS, Santa Monica, CA, USA.
Chadi NabhanCaris Life Sciences, Phoenix, AZ, USA.
Jeffrey S MillerMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Justin H HwangMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Emmanuel S AntonarakisMasonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0003-0031-9655

Funding

Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI J SUNIL RAO · 1995 to 2026
$48.2M
NCI NIH HHS P01 CA065493
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40796671
PMCPMC12643912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.